IRIS
ORIGONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.453
NA - Nord America 1.457
EU - Europa 1.246
SA - Sud America 753
AF - Africa 40
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.395
SG - Singapore 1.105
CN - Cina 668
BR - Brasile 624
SE - Svezia 414
IT - Italia 317
HK - Hong Kong 312
VN - Vietnam 186
RU - Federazione Russa 125
DE - Germania 90
GB - Regno Unito 59
AR - Argentina 49
FI - Finlandia 45
IN - India 43
MX - Messico 30
NL - Olanda 29
EC - Ecuador 27
ID - Indonesia 27
ES - Italia 26
AT - Austria 25
IE - Irlanda 24
CA - Canada 22
ZA - Sudafrica 22
PL - Polonia 20
FR - Francia 19
PT - Portogallo 19
JP - Giappone 18
BD - Bangladesh 16
CO - Colombia 15
PY - Paraguay 15
TR - Turchia 15
IQ - Iraq 13
CL - Cile 9
PK - Pakistan 9
UA - Ucraina 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
AL - Albania 5
MA - Marocco 5
UZ - Uzbekistan 5
EG - Egitto 4
LT - Lituania 4
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
IR - Iran 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KZ - Kazakistan 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
EU - Europa 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
NI - Nicaragua 1
PH - Filippine 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 5.954
Salva come PNG Salva come JPEG
Città #
Singapore 442
Hong Kong 311
Dallas 274
Ashburn 244
Shanghai 163
Hefei 145
Lawrence 135
Princeton 135
Beijing 133
Ho Chi Minh City 84
Milan 79
São Paulo 60
Moscow 56
New York 49
Boardman 41
Hanoi 38
Los Angeles 38
Helsinki 32
Rio de Janeiro 24
Dublin 23
Nuremberg 22
Munich 19
Tokyo 18
Pune 17
Rome 17
Santa Clara 17
Bologna 15
Johannesburg 15
Belo Horizonte 14
Guangzhou 14
Porto 14
Warsaw 13
Brasília 12
Brooklyn 12
London 12
Orem 12
Atlanta 11
Chennai 11
Chicago 11
Guayaquil 11
Poplar 11
Boston 10
Denver 10
Manchester 10
Vienna 10
Porto Alegre 9
Querétaro 9
Tianjin 9
Turku 9
Washington 9
Ankara 8
Campinas 8
Houston 8
Islington 8
Mexico City 8
Montreal 8
Buenos Aires 7
Da Nang 7
Frankfurt am Main 7
Guarulhos 7
Hải Dương 7
Phoenix 7
Ribeirão Preto 7
Sorocaba 7
Stockholm 7
Surabaya 7
Amsterdam 6
Bergamo 6
Carpineto Romano 6
Catania 6
Contagem 6
Cortona 6
Haiphong 6
Juiz de Fora 6
Piracicaba 6
Salvador 6
San Jose 6
The Dalles 6
Asunción 5
Cape Town 5
Curitiba 5
Dubai 5
Naples 5
Nova Iguaçu 5
Novara 5
Santo André 5
Tashkent 5
Tirana 5
Turin 5
Bauru 4
Blumenau 4
Cesano Boscone 4
Charlotte 4
Ciudad del Este 4
Council Bluffs 4
Goiânia 4
Jiaxing 4
Lima 4
Lucknow 4
Nootdorp 4
Totale 3.178
Salva come PNG Salva come JPEG
Nome #
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 97
Surgical approaches to in-utero spina bifida repair: a Systematic Review 90
The Peritoneal Neovagina after Davydov's Laparoscopic Procedure in Mayer-Rokitansky-Küster-Hauser Syndrome: Morphology and Ultrastructure Investigation of the New Epithelium 87
Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study 85
Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies 85
[HPV vaccination: not only female adolescents and not only prophylactic. Review and position paper of the Italian HPV Study Group (IHSG)] 83
Papillomavirus umano (HPV) con associata Sindrome della Vestibolite Vulvare e papillomatosi vestibolare 79
Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia - Italian Study Group on vulvar disease 79
Citologia, colposcopia, istologia ed ibridazione molecolare nella diagnosi di infezione cervicale da HPV: studio comparativo 71
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study 70
An alternative approach for the treatment of vaginal atrophy 70
Caesarean section: a woman's right? 69
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 68
Antigens of HLA system in patients with vulvar lichen sclerosus 67
Cervical Human papillomavirus in transplanted Italian women: a long-term prospective follow-up study. 67
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 67
Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia 67
Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study 66
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 65
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 65
Antigens of the HLA system in women with vulvar lichen sclerosus. Association with HLA-B21 64
HPV Opportunistic Vaccination: A Literature Review and a Single-Center Experience in Northern Italy through the COVID-19 Pandemic 63
Bombelli - Castiglioni Ginecologia e Ostetricia 63
TERAPIA DELLA SM CON FARMACI BIOLOGICI: la questione HPV 63
CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix 62
Incidenza, indicazioni e orientamenti dell'isterectomia ostetrica 58
An oral component: vaginal lesions were associated with gingival symptoms 58
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study 57
Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment—Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology 56
Acute isolated tubal torsion in pregnancy due to twisted Morgagni hydatid 55
Results from an Italian consensus conference on prevention and management of infections in MS patients treated with biological and non biological disease modifying drugs 54
Progetto SOPHY: Studio osservazionale sul pH vaginale e sullo stile di vita della donna nelle diverse età e condizioni fisiopatologiche. Parte I 53
Low-Malignant Schwannoma of the Cervix in Pregnancy: A Case Report and Literature Systematic Review 53
Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art 51
Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IVA FIGO 51
La sindrome ab ingestis in corso di taglio cesareo: incidenza e condotta terapeutica 50
Results from an italian Consensus Conference on prevention and management of infections in multiple sclerosis patients treated with biological and non biological disease modifying drugs 50
An unusual diagnosis of primary Non-Hodgkin lymphoma of the vagina stage IE 49
Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review 48
Micropapillomatosi del vestibolo vulvare e HPV: indagine biomolecolare su prelievo citologico: risultati preliminari 47
Il prurito vulvare non va sottovalutato 46
La diagnostica strumentale e di laboratorio in oncologia ginecologica 45
Prognostic value of pathological patterns of lymphnode positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO 44
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy 43
Splenic hamartoma in pregnancy 43
Spontaneous post-cesarean regression of massive cervico-vaginal condylomatosis in pregnancy 43
Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer 42
Topical testosterone in the treatment of vulvar lichen sclerosus 42
SOPHY project: an observational study of vaginal PH, lifestyle and correct intimate hygiene in women of different physiopathological conditions. Part II 41
Fractional CO2 laser improves sexual function in women with vulvovaginal atrophy 41
Melanoma of the vulva: A pathologic study of 8 cases 41
Topical oxatomide: An alternative approach for the treatment of vulvar lichen sclerosus 41
I fattori di rischio per il tumore invasivo della vulva 41
In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix and HPV-Type Impact: Pathologic Features, Treatment Options, and Follow-Up Outcomes—Cervical Adenocarcinoma Study Group (CAS-Group) 40
Topical testosterone in the treatment of vulvar lichen sclerosus 40
High frequency of normal karyotypes in endometrial adenocarcinomas 40
Sebaceous glands in the uterine portio. A report of two cases 40
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice 40
Efficacy of topical oxatomide in women with pruritus vulvae 39
I nuovi biomarcatori: p16INK4a e Ki-67 (CINtec PLUS) 39
Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper 39
TOPICAL TESTOSTERONE IN THE TREATMENT OF VULVAR LICHEN-SCLEROSUS 38
Spinocellular carcinoma of the vulva. Critical review of the surgical case histories from 1967-1989 38
Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, italian pilot study 38
Topical testosterone in the treatment of vulvar Lichen Sclerosus 38
Gynecologic and Obstetric Surgery 38
Worsening immunodeficiency correlates with increasing frequency of HPV-correlated cervical intraepithelial lesions in HIV-infected women 38
Lichen sclerosus of the vulva 37
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): A promising perspective 37
Therapy of vulvar lichen sclerosus: testosterone vs. placebo. A randomized study 37
The coexistence of HPV16 and 18 related high grade intraepithelial neoplasia and microinvasive endocervical adenocarcinoma 37
Preneoplastic lesions of the vulva 37
Test HPV e prevenzione della carcinoma della cervice uterina - Dalle evidenze alla clinica. Guida Pratica 2010 37
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement 37
Valuable expression of MIB1 index in serous ovarian tumors 36
Human papillomavirus DNA and pap tests: The need for cotesting in opportunistic setting during the transition time 36
NEURAL BLOCKADE UNDER NEUROPHYSIOLOGICAL GUIDANCE FOR CHRONIC PELVIC PAIN IN 110 WOMEN AFFECTED BY PUDENDAL NEURALGIA (PN) 36
Elementi di chirurgia ginecologica benigna 36
Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic 35
Human papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosis 35
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma 35
Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study 35
Studio di progressione della Low Grade SIL in relazione alla tipizzazione virale dell'HPV: Risultati preliminari 35
DETERMINANTS OF INVASIVE VULVAR CANCER RISK - AN ITALIAN CASE-CONTROL STUDY 35
Protein S100 and cytokeratins A,B,C in vulvar lichen sclerosus: immunohistochemical study 34
Goserelin depot therapy for heavy dysfunctional uterine bleeding in severely anemic women 34
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 34
Serous borderline-malignancy tumors of the ovary 34
HPV-DNA test: indicazioni e strategie di utilizzo. in: APOG Aggiornamento Permanente in Ostetricia e Ginecologia 34
Gestione della paziente con pap test anormale. Linee Guida SICPCV 2006 34
The Prognostic Value of DNA Ploidy Determination in Endometrial Cancer 33
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 33
Esiti riproduttivi dopo chirurgia conservativa ovarica per neoplasie "borderline malignancy" 33
HPV-Testing in follow-up of patients treated for CIN2+ lesions 33
Vulvar dystrophies: diagnostic problems and therapeutic indications 33
Lesioni squamose intraepiteliali della cervice uterina (SIL): tipizzazione e significato prognostico dei genotipi di HPV 33
Human papillomavirus viral load expressed as relative light units (RLU)correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS)cytology 33
Neurobiological mechanisms of pelvic pain 33
VIN usual type - From the past to the future 32
HPV DNA IN SEDE EXTRALESIONALE: UN POSSIBILE MARCATORE DI DIFFUSIONE METASTATICA NEL CARCINOMA CERVICALE 32
Totale 4.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 46 8 16 12 12 9 11 14 10
2022/2023762 313 172 41 2 3 89 33 50 33 7 5 14
2023/2024412 16 45 44 89 17 55 22 26 6 12 23 57
2024/20251.809 228 21 30 72 58 134 289 155 339 158 166 159
2025/20262.866 457 545 404 949 457 54 0 0 0 0 0 0
Totale 6.015